Vida Health is a technology company.
Vida Health has raised $187.0M across 5 funding rounds.
Vida Health has raised $187.0M in total across 5 funding rounds.
Vida Health is a virtual care technology company delivering personalized programs for chronic conditions like obesity, diabetes, hypertension, and mental health issues through a mobile platform.[2][3][4] It serves employers, health plans, and individuals with a whole-person approach combining health coaching, anti-obesity medications (including GLP-1s), therapy, nutritional guidance, and lifestyle support, aiming to eradicate chronic disease and lower total care costs.[2][4][5] The platform integrates with over 100 apps, devices, biometrics, and claims data for tailored plans, reporting strong outcomes such as 7-10% average weight loss in a year, 1.4-point A1C reductions for diabetes, and 61% depression symptom reduction over six months.[3][4]
Growth momentum includes scaling via enterprise solutions, with past funding like a $25 million round in 2020 to expand virtual care amid rising demand.[3] Employee surveys highlight mission alignment as a key retention driver, with 100% citing it as their primary reason to stay.[5]
Vida Health emerged as a mobile-first solution for wellness and chronic care, pairing users 1:1 with human health coaches using evidence-based methods and data integration.[3] While specific founders are not detailed in available sources, the company built traction through personalized plans addressing weight loss, stress, exercise, nutrition, and reversal of conditions like pre-diabetes, diabetes, hypertension, high cholesterol, anxiety, and depression.[3] A pivotal moment came in 2020 with a $25 million raise to scale its coach network and meet surging virtual care needs during the pandemic.[3] This positioned Vida as a leader in human-centric digital health, evolving from individual wellness to enterprise-scale chronic disease management.[2][6]
Vida Health rides the virtual care and GLP-1 boom, capitalizing on post-pandemic demand for remote chronic disease management amid rising obesity and mental health crises.[2][3] Timing aligns with employer/health plan shifts to value-based care, where integrated platforms reduce costs—Vida's turnkey obesity solution fits seamlessly into ecosystems, influencing scalable population health.[2] Market forces like medication access (e.g., semaglutide) and data interoperability favor its model, positioning it to shape digital health by bridging tech with clinical impact and preventing disease progression across millions.[4]
Vida Health is primed to expand enterprise adoption, leveraging outcomes data to capture more B2B market share in obesity and cardiometabolic care as GLP-1 demand grows.[2][8] Trends like AI-enhanced coaching and payer integrations will accelerate its trajectory, potentially evolving influence through partnerships that redefine preventive virtual care. With a mission fueling team retention, expect sustained innovation in whole-person health, transforming chronic disease burdens into manageable, cost-effective realities.[5] This builds on its foundation as a proven scaler in digital therapeutics.
Vida Health has raised $187.0M in total across 5 funding rounds.
Vida Health's investors include Canvas Ventures, General Atlantic, Mountain Group Partners, Summit Partners, Techstars, Michael Stoppelman, AME Cloud Ventures, Dispersion Capital, Hardware Club, Heavybit, Nokia Growth Partners, Storm Ventures.
Vida Health has raised $187.0M across 5 funding rounds. Most recently, it raised $29.0M Venture Round in November 2023.